Reaction
Application Site Papules reporting signals
As of the last recalculation, Application Site Papules appears in 1,041 FAERS reports alongside 13 co-occurring drug terms. The strongest observed disproportionality signal is NICOTINE (PRR 109.5).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Nicotine | 183 | 109.5 | 110.0 |
| Minoxidil Foam 5% (Womens) | 154 | 109.4 | 109.9 |
| Minoxidil | 159 | 83.3 | 83.6 |
| Oxybutynin | 28 | 19.6 | 19.6 |
| Glycerin, Lidocaine | 13 | 18.8 | 18.8 |
| Docosanol | 13 | 17.9 | 18.0 |
| Tretinoin | 7 | 17.4 | 17.4 |
| Nicotine Polacrilex | 29 | 15.6 | 15.6 |
| Buprenorphine | 44 | 9.9 | 9.9 |
| Methylphenidate | 12 | 8.4 | 8.4 |
| Botulinum Toxin Type A | 5 | 8.1 | 8.1 |
| Diclofenac Potassium | 4 | 7.4 | 7.4 |
| Salicylic Acid | 7 | 2.7 | 2.7 |